{"id":"W4410417349","doi":"10.1136/bmjopen-2025-100159","title":"Efficacy and safety of novel complement inhibitors in atypical haemolytic uremic syndrome: a protocol for systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Intensive care medicine; Systematic review; Meta-analysis; Thrombotic microangiopathy; Cochrane Library; Protocol (science); MEDLINE; Evidence-based practice; Atypical hemolytic uremic syndrome; Publication bias; Orphan drug; Alternative medicine; Bioinformatics; Internal medicine; Pathology; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06388956,0.00587334,0.01920717,0.01053426,0.002867235,0.0063828,0.005331065,0.006558894,0.05928318],"category_scores_gemma":[0.08987776,0.003716011,0.03020385,0.01021181,0.003117389,0.00568951,0.004639042,0.005457271,0.005228904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01232088,"about_ca_system_score_gemma":0.04130374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005153725,"about_ca_topic_score_gemma":0.009900074,"domain_scores_codex":[0.9676431,0.01373722,0.01096757,0.002550157,0.003751834,0.001350137],"domain_scores_gemma":[0.9647769,0.01500235,0.007576495,0.003811512,0.007617825,0.001214815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005136511,0.0001412518,0.0004993142,0.946872,0.01105806,0.0002969367,0.0006373645,0.0009069694,0.0007765455,0.002079989,0.0149963,0.01659876],"study_design_scores_gemma":[0.04736465,0.00244183,0.006084466,0.649897,0.1104542,0.000616495,0.0009445723,0.002496048,0.002448224,0.01296397,0.1636597,0.0006288749],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.0007453874,0.008187888,0.003629824,0.0007324747,0.0005010246,0.9780513,0.007164343,0.0002515003,0.0007363394],"genre_scores_gemma":[0.0007853349,0.002303935,0.003981816,0.0002543755,0.00003111751,0.9915643,0.0006900505,0.0000155857,0.0003735347],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.06388956,"threshold_uncertainty_score":0.3378844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1548612730056794,"score_gpt":0.456534877715915,"score_spread":0.3016736047102356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}